Boost Your Fertility? How Daily Tadalafil Could Be a Game-Changer
"Research suggests that a daily dose of Tadalafil, commonly used for erectile dysfunction, may improve sperm quality in men."
Erectile dysfunction (ED) is a common concern for men, and Tadalafil, a phosphodiesterase 5 (PDE5) inhibitor, is a well-known treatment option. But Tadalafil's potential benefits may extend beyond just treating ED. Emerging research suggests it could also play a role in improving sperm quality.
Sperm motility, concentration, and overall semen volume are critical factors for male fertility. Many couples face challenges when trying to conceive, and male infertility contributes significantly to these difficulties. Finding ways to safely and effectively enhance sperm parameters is an ongoing area of research.
A recent study investigated the effects of daily Tadalafil administration on sperm quality in a group of men with psychogenic ED. The findings revealed promising improvements in several key sperm characteristics. This article explores the study's results, what they might mean for male fertility, and the potential mechanisms behind these improvements.
Current Evidence and Impact
Varicocele is described as the leading correctable cause of male infertility, occurring incidentally in approximately 15% of men and in 35%–40% of men investigated for infertility. In one study, patients receiving tadalafil experienced increases in sperm volume, concentration, and motility, although the percentage of typical forms did not improve; the placebo group had no significant improvement. Another study reported no adverse effects on sperm concentration, sperm count per ejaculate, motility, morphology, or reproductive hormones. Among men aged 45 years or older, a 50% or greater reduction in sperm concentration occurred in 7.0% of placebo users and 9.1% of tadalafil users after the treatment-free period.
Current Treatment Context
Male-infertility care generally requires evaluation of multiple possible causes rather than assuming that one medication will address every case. Treatment choices may depend on the underlying diagnosis, the couple's circumstances, and the goals of care. Because evidence for tadalafil as a fertility treatment remains limited and variable, it should be considered only with individualized medical guidance.
From Approval to Fertility Research
Tadalafil's development involved ICOS Corporation and Eli Lilly, with Lilly acquiring ICOS in 2007 for $2.3 billion. In May 2002, Lilly ICOS reported to the American Urological Association that clinical trials showed tadalafil could be effective for up to 36 hours, and the FDA approved it one year later. A 2003 report found that daily tadalafil at 10 or 20 mg for six months had no adverse effects on spermatogenesis or reproductive hormone levels in men older than 45 years.
Tadalafil: More Than Just an ED Drug?
The study, published in Archivio Italiano di Urologia e Andrologia, enrolled 27 men aged 19 to 35 experiencing psychogenic ED. Psychogenic ED refers to ED caused by psychological factors rather than physical ones. Importantly, the men were unaware of their fertility status before participating.
- Semen volume
- Sperm concentration
- Sperm motility (both total and progressive)
- Percentage of normal sperm
What Recent Evidence Suggests
Recent research has examined whether PDE5 inhibitors, including tadalafil, may have effects beyond treating erectile dysfunction. Reviews and clinical studies suggest possible effects on male-infertility outcomes, but the evidence does not establish tadalafil as a universal fertility treatment. Findings should therefore be interpreted as an evolving research area rather than as definitive proof of improved pregnancy or live-birth rates.
Limits and Uncertainties
A potential benefit for erectile function or selected semen measures does not necessarily translate into improved fertility for every couple. Responses may differ according to the cause of infertility, and available research may not resolve all clinically important outcomes. Tadalafil should therefore not be presented as a guaranteed solution or as a substitute for a complete infertility evaluation.
Tadalafil Compared With Other ED Drugs
The main FDA-approved erectile-dysfunction drugs listed by Harvard Health are sildenafil, tadalafil, vardenafil, and avanafil. A March 2026 study proposed a head-to-head, real-world comparison of four PDE5 inhibitors and hypothesized that sildenafil would show a distinctive efficacy and safety profile compared with tadalafil and vardenafil. Drug selection depends on factors such as lifestyle and possible medication interactions, while comparison resources evaluate differences in uses, ratings, cost, side effects, and interactions.
What Does This Mean for Your Fertility Journey?
The study's findings suggest that daily Tadalafil administration could potentially improve sperm quality in some men, particularly those with psychogenic ED. However, it's important to note that this was a relatively small study, and further research is needed to confirm these results and determine the long-term effects.
A Cautious Synthesis
Meta-analytic and review evidence describes male infertility as a worldwide problem with limitations in available treatment and identifies PDE5 inhibitors as first-choice treatments for erectile dysfunction. The same research suggests that PDE5 inhibitors may have some effects on male-infertility measures, but this does not establish that tadalafil alone improves fertility for all patients. A separate study explored 12 weeks of once-daily tadalafil in men with psychogenic erectile dysfunction, reinforcing the need to distinguish treatment populations and outcomes.
What Research Still Needs to Answer
Future research should clarify which patients, if any, are most likely to benefit from daily tadalafil in fertility-related care. Studies also need to distinguish changes in semen measurements from outcomes that matter directly to couples, such as conception and live birth. Until that evidence is clearer, daily tadalafil is best approached as a topic for clinical investigation rather than a proven fertility-enhancement strategy.
The Wider Fertility Context
Infertility is a complex clinical problem, and medication alone may not address its underlying causes. Access to evaluation, specialist care, and appropriate treatment can shape real-world outcomes as much as any individual drug. A broader approach should therefore combine careful diagnosis with realistic discussion of benefits, uncertainties, and alternatives.
Patient-Centered Implications
A study of men with male accessory gland infection reported that tadalafil 5 mg daily improved sexual function, sperm quality, and symptom severity and might prevent progression into complicated forms. Another study found that maximum oral doses of sildenafil 100 mg or tadalafil 20 mg did not negatively affect the sperm acrosome reaction, supporting safety for men in infertile couples seeking pregnancy. These findings may be relevant to patients whose fertility concerns overlap with erectile or sexual-function difficulties, but they do not mean that every patient will experience the same benefits.
The researchers propose that Tadalafil's positive effects on sperm quality may be related to its impact on nitric oxide (NO) levels in the body. NO plays a crucial role in various physiological processes, including vasodilation (the widening of blood vessels) and sperm function. Tadalafil may enhance NO-mediated mechanisms in the prostate and testicular tissue, leading to improved sperm production and motility.
If you and your partner are facing fertility challenges, it's essential to consult with a healthcare professional for a comprehensive evaluation. While Tadalafil may offer a potential avenue for improving sperm quality, it's not a guaranteed solution, and other factors could be contributing to infertility. A doctor can help determine the underlying causes and recommend the most appropriate treatment options for your specific situation.